Development and validation of a machine learning model to evaluate survival in patients with newly diagnosed breast cancer with liver metastasis - Top-Institutions - MDSpire

Development and validation of a machine learning model to evaluate survival in patients with newly diagnosed breast cancer with liver metastasis

  • By

  • Yao Wang

  • Yu Yue

  • Xu-Chen Cao

  • June 16, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Tianjin Medical University Cancer Institute and Hospital
    Tianjin Medical University Cancer Institute and Hospital

    Tianjin, Tianjin

    Key Differentiators

    • Oncology

  • #2

    North Estonia Medical Centre (NEMC) Foundation
    North Estonia Medical Centre (NEMC) Foundation

    Tallinn, Harju

    Key Differentiators

    • Oncology

  • #3

    Stanford NSCLC Radiogenomics
    Stanford NSCLC Radiogenomics

    Stanford, California

    Key Differentiators

    • Oncology

Original Source(s)

Development and validation of a machine learning model to evaluate survival in patients with newly diagnosed breast cancer with liver metastasis

  • by Yao Wang, Yu Yue, Xu-Chen Cao

  • June 16, 2026

Related Content

Oncology Organization and Oncologist Networks Under Medicare Advantage Plans

Liquid biopsy, multi-cancer early detection, and artificial intelligence: new frontiers in cancer screening from a technological and immunological perspective

The role of LARP1 in breast cancer progression: from prognosis to immune microenvironment remodeling